This created an upsurge in illegal cannabis use and patients buying their medicine from unregulated sources. As a response, lawmakers put into effect the Marijuana for Medical Purposes Regulations (MMPR) in April 2014. These regulations stipulated that licensed medical patients must buy their cannabis from a Licensed Producer (LP) who was regulated by Health Canada.
As mentioned above, CBD is no longer considered a Schedule I controlled substance under the Farm Act. However, under the DEA’s definition, it remains on the list. This allows for individual states to create exceptions to the status of CBD, even when cultivated from hemp plants grown legally under the act. It also maintains illegal status for any CBD sourced from plants produced in settings that are not consistent with that Act, or by an unlicensed grower. It is expected that more clarification on the status of CBD will come early this year (2019).